middle.news
Microba Reports 92% Growth in Core Testing Revenue and $7m Cost Savings Target
9:03am on Thursday 16th of July, 2026 AEST
•
Healthcare
Read Story
Microba Reports 92% Growth in Core Testing Revenue and $7m Cost Savings Target
9:03am on Thursday 16th of July, 2026 AEST
Key Points
FY26 core testing revenue up 92%, volume up 78%
New GI Navigator test launch on track for September 2026
43 Australian enterprise accounts signed, test sales up 87% QoQ
$7 million annualised cost savings targeted, full benefit in H1 FY27
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Microba Life Sciences (ASX:MAP)
OPEN ARTICLE